Exhibit 10.2



 Exhibit 10.2 
 UNIT PURCHASE AGREEMENT 
 This UNIT PURCHASE AGREEMENT, dated as of June
    , 2011, is entered into by and among AG Mortgage Investment Trust, Inc., a Maryland corporation (the “Issuer”) and each purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser” and collectively, the “Purchasers”). 
 W I T N E S S E T
H: 
 WHEREAS, subject to the terms and conditions set forth in this agreement, pursuant to a private placement exempt
from registration under the Securities Act of 1933, as amended (the “Securities Act”), each Purchaser desires to purchase from the Issuer units (the “Units”), consisting of one share of Common Stock, par value $0.01
per share, of the Issuer (collectively, the “Shares”) and a warrant to purchase 0.5 shares of Common Stock that is exercisable commencing on the date of Closing and with a term of exercise equal to seven (7) years from the date
of Closing and an exercise price of $20.50, subject to adjustment as set forth in the Warrant Agreement substantially in the form attached hereto as Exhibit A (collectively, the “Warrants”) for a purchase price of $20.00 per
Unit (the “Unit Purchase Price”), and the Issuer desires to issue and sell the Units to each Purchaser in exchange for the Unit Purchase Price, in each case on the terms and subject to the conditions described herein.

 NOW THEREFORE, in consideration of the premises and of the mutual agreements, covenants and provisions in this Agreement
and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto hereby agree as follows: 
 ARTICLE 1 
 PURCHASE AND SALE 

1.1 Purchase and Sale of the Units. Subject to (a) the terms and conditions set forth in this Agreement and (b) the
Issuer’s issuance and sale of [—] shares (the “IPO Shares”) of Common Stock to the underwriters (the “Underwriters”) named in the underwriting agreement with
the issuer (the “Underwriting Agreement”) in connection with the Issuer’s initial public offering (the “IPO”) pursuant to and in accordance with the Underwriting Agreement (the “IPO Closing”),
the Issuer shall issue and sell to each Purchaser, and each Purchaser shall purchase from the Issuer, the number of Units set forth on such Purchaser’s signature page, in exchange for payment by such Purchaser of the Unit Purchase Price per
Unit. 
 1.2 Closing. Subject to the terms and upon the satisfaction of the conditions of this Agreement and the
occurrence of the IPO Closing, the closing of the purchase and sale of the Units (the “Closing”) shall take place on the date of the IPO Closing at the offices of counsel to the Issuer, McDermott Will & Emery LLP located at
340 Madison Avenue, New York, New York 10173, or at such other place as the parties hereto shall agree in writing. 
 1.3
Closing Deliveries. At the Closing, (a) each Purchaser shall deliver to the Issuer the Unit Purchase Price per Unit purchased by such Purchaser by wire transfer of immediately available funds to an account designated by the Issuer in
writing at least two (2) business days prior to the date of the Closing, (b) the Units will immediately separate into Shares and Warrants and (c) the Issuer shall issue such Shares and the Warrants, and deliver certificates
representing the Shares and the Warrants to each Purchaser, as set forth on such Purchaser’s signature page. 







 ARTICLE 2 
 REPRESENTATIONS AND WARRANTIES OF THE ISSUER 
 The Issuer represents and warrants to each
Purchaser as follows: 
 2.1 Formation and Good Standing. The Issuer is a corporation duly incorporated and validly
existing under and by virtue of the laws of the State of Maryland and is in good standing with the State Department of Assessments and Taxation of Maryland. 
 2.2 Authorization and Validity of Agreement. The Issuer has all requisite power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution and delivery of this Agreement, the performance by the Issuer of its obligations hereunder and the consummation of the transactions contemplated hereby have been duly authorized by all requisite
corporate action of the Issuer. This Agreement constitutes a legal, valid and binding obligation of the Issuer, enforceable against the Issuer in accordance with its terms, except that the enforceability of this Agreement against the Issuer may be
limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws affecting the enforcement of creditors’ rights generally, public policy and general equitable principles. 

2.3 No Conflicts; Consents. The execution, delivery and performance of this Agreement by the Issuer and the consummation by the
Issuer of the transactions contemplated hereby do not and will not conflict with, contravene, result in a violation or breach of or default under (with or without the giving of notice or the lapse of time, or both), permit any party to terminate,
amend or accelerate the provisions of, or result in the imposition of any claim, lien, pledge, deed of trust, option, charge, security interest, hypothecation, encumbrance, right of first offer, voting trust, proxy, right of third parties or other
restriction or limitation of any nature whatsoever (each, a “Lien”), or any obligation to create any Lien, upon any of the property or assets of the Issuer under (a) any contract, agreement, indenture, letter of credit,
mortgage, security agreement, pledge agreement, deed of trust, bond, note, guarantee, surety obligation, warranty, license, franchise, permit, power of attorney, lease, instrument or other agreement (each, a “Contract”) to which the
Issuer is a party or by which any of its property or assets may be bound or (b) any provision of any organizational document of the Issuer. 
 2.4 Authorization of the Shares. The Shares have been duly authorized and, when issued in accordance with this Agreement, will be duly and validly issued, fully paid and non-assessable and will be
free and clear of all Liens, other than restrictions on transfer imposed by the Securities Act and applicable state securities laws. The Common Stock issuable upon exercise of the Warrants (the “Warrant Shares”), when issued in
accordance with the terms of the Warrants, will be validly issued, fully paid and non-assessable and will be free and clear of all Liens, other than restrictions on transfer imposed by the Securities Act and applicable state securities laws.


  
 2 








 2.5 Exemption from Registration; No Integration; No General Solicitation. 

(a) Subject to the accuracy of the representations and warranties of the Purchasers, it is not necessary in connection with the offer,
sale and delivery of the Units to the Purchasers in the manner contemplated by this Agreement to register the Units (or the Shares and Warrants comprising the Units) under the Securities Act. 

(b) Neither the Company nor any affiliate (as defined in Rule 501(b) of Regulation D under the Securities Act) of the Company has
directly, or through any agent, (i) sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act) which is or will be integrated with the sale of the Units (or the Shares
and Warrants comprising the Units) in a manner that would require the registration under the Securities Act of the Units (or the Shares and Warrants comprising the Units) or (ii) offered, solicited offers to buy or sold the Units (or the Shares
and Warrants comprising the Units) by any form of general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the meaning of
Section 4(2) of the Securities Act. 
 ARTICLE 3 
 REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS 
 Each Purchaser represents and warrants to the
Issuer as follows: 
 3.1 Formation and Good Standing. If a business entity, such Purchaser is duly organized, validly
existing and in good standing under the jurisdiction and laws of the jurisdiction of its organization. 
 3.2 Authorization
and Validity of Agreement. Such Purchaser has all requisite power and authority to execute and deliver this Agreement, to perform his, her or its obligations hereunder and to consummate the transactions contemplated hereby. The execution and
delivery of this Agreement, the performance by such Purchaser of his, her or its obligations hereunder and the consummation of the transactions contemplated hereby have been duly authorized by such Purchaser and, if a business entity, by all
requisite corporate action of such Purchaser. This Agreement constitutes a legal, valid and binding obligation of such Purchaser, enforceable against such Purchaser in accordance with its terms, except that the enforceability of this Agreement
against such Purchaser may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws affecting the enforcement of creditors’ rights generally, public policy and general equitable principles.

 3.3 No Conflicts; Consents. The execution, delivery and performance of this Agreement by such Purchaser and the
consummation by such Purchaser of the transactions contemplated hereby do not and will not conflict with, contravene, result in a violation or breach of or default under (with or without the giving of notice or the lapse of time, or both), permit
any party to terminate, amend or accelerate the provisions of, or result in the imposition of any Lien (or any obligation to create any Lien) upon any of the property or assets of such Purchaser under (a) any Contract to which such Purchaser is
party or by which any of his, her or its property or assets may be bound or (b) if a business entity, any provision of any organizational document of such Purchaser. 

  
 3 








 3.4 Offering Representations. 

(a) Such Purchaser hereby acknowledges that the Units (and the Shares and Warrants comprising the Units) have not been registered under
the Securities Act and may not be offered or sold except pursuant to registration or to an exemption from the registration requirements of the Securities Act and that the certificates evidencing the Shares and Warrants comprising the Units will bear
a legend to that effect. The Units to be acquired by such Purchaser pursuant to this Agreement are being acquired for his, her or its own account and with no intention of distributing or reselling the Units (or the Shares and Warrants comprising the
Units) or any part thereof in any transaction that would be in violation of the securities laws of the United States, any state of the United States or any foreign jurisdiction. Such Purchaser further agrees that he, she or it has not entered and
prior to the Closing will not enter into any Contract with respect to the distribution, sale, transfer or delivery of the Units. 
 (b) Such Purchaser is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the Securities Act, as presently in effect. 

(c) Such Purchaser has adequate means of providing for his, her or its current needs and personal contingencies, that such Purchaser has
no need now, and anticipates no need in the foreseeable future, to sell the Shares or Warrants, and such Purchaser currently has sufficient financial liquidity to afford a complete loss of such Purchaser’s investment in the Issuer. 

(d) The overall commitment of such Purchaser to investments which are not readily marketable is not excessive in view of such
Purchaser’s net worth and financial circumstances, and any purchase of the Units will not cause such commitment to become excessive. 
 (e) Such Purchaser is sufficiently experienced in financial and business matters to be capable of evaluating the merits and risks involved in purchasing the Units and to make an informed decision relating
thereto. 
 (f) In addition to reviewing the Issuer’s Private Placement Memorandum, such Purchaser has carefully considered
the potential risks relating to the Issuer and a purchase of the Units, and fully understands that the Units are speculative investments which involve a high degree of risk of loss of such Purchaser’s entire investment. Among others, such
Purchaser has carefully considered each of the risks described in the Private Placement Memorandum and the documents incorporated therein by reference. Such Purchaser has been furnished with the materials relating to the business, operations,
financial condition, assets and liabilities of the Issuer and other matters relevant to such Purchaser’s investment in the Units which have been requested by such Purchaser. Such Purchaser has had adequate opportunity to ask questions of, and
receive answers from, the officers, employees, agents, accountants, and representatives of the Issuer concerning the business, operations, financial condition, assets and liabilities of the Issuer and all other matters relevant to such
Purchaser’s investment in the Units. 

  
 4 








 (g) Such Purchaser (i) did not become interested in purchasing Shares or Warrants by
means of the registration statement on Form S-11 filed by the Issuer with the U.S. Securities and Exchange Commission in connection with the IPO (the “Registration Statement”), (ii) was not identified or contacted through the
marketing of the IPO and (iii) did not independently contact the Issuer as a result of the general solicitation by means of the Registration Statement. 
 ARTICLE 4 
 COVENANTS 

4.1 Registration Rights. Subject to the consummation of the IPO Closing and the Closing, each party hereto shall enter into that
certain Registration Rights Agreement in the form attached hereto as Exhibit B with respect to the Shares and the Warrant Shares. 
 4.2 Lock-up Agreements. Each Purchaser other than AG Funds, L.P. (“AG Funds”) shall enter into a lock-up agreement substantially in the form of Exhibit C-1 attached hereto under
which such Purchaser will agree, subject to the terms and conditions of the lock-up agreement, not to sell the Shares or the Warrant Shares for 180 days from the Closing. AG Funds will enter into a lock-up agreement substantially in the form of
Exhibit C-2 attached hereto under which AG Funds will agree, subject to the terms and conditions of the lock-up agreement, not to sell the Shares or the Warrant Shares for two years from the Closing. 

4.3 Further Assurances. Each party hereto shall execute and deliver such instruments and take such other actions prior to and/or
after the Closing as the other party hereto may reasonably request in order to carry out the intent of this Agreement, including, without limitation, obtaining any required consents or approvals from third parties, if any. 

ARTICLE 5 

CONDITIONS PRECEDENT TO THE OBLIGATIONS 
 5.1 Mutual Conditions. Each of the Issuer’s and the Purchasers’ respective obligations to consummate the purchase and sale of the Units at the Closing pursuant to and in accordance with
this Agreement are subject to the fulfillment of the following conditions: (a) the occurrence of the IPO Closing, (b) the absence of any order, decree, judgment or injunction of a court of competent jurisdiction or other governmental or
regulatory authority precluding the consummation of the purchase and sale of the Units contemplated hereby and (c) there shall not have been any action taken or any statute, rule or regulation enacted, promulgated or deemed applicable to, the
purchase and sale of the Units contemplated hereby by any court, governmental agency or regulatory or administrative authority that makes consummation of such transactions illegal. 

5.2 Conditions to the Obligations of the Issuer. The Issuer’s obligation to consummate the purchase and sale of the Units at
the Closing pursuant to and in accordance with this Agreement is subject to the fulfillment (or waiver by the Issuer) of the following conditions: (a) the representations and warranties of each Purchaser contained in or made pursuant to this


  
 5 








 
Agreement shall be deemed to have been made again at and as of the Closing and shall then be true and accurate and (b) each Purchaser shall have performed and complied in all material
respects with his, her or its obligations required by this Agreement to be performed or complied with by him, her or it prior to or at the Closing. 
 5.3 Conditions to the Obligations of Each Purchaser. Each Purchaser’s obligation to consummate the purchase and sale of the Units at the Closing pursuant to and in accordance with this
Agreement is subject to the fulfillment (or waiver in writing by each Purchaser) of the following conditions: (a) the representations and warranties of the Issuer contained in or made pursuant to this Agreement shall be deemed to have been made
again at and as of the Closing and shall then be true and accurate and (b) the Issuer shall have performed and complied in all material respects with its obligations required by this Agreement to be performed or complied with by it prior to or
at the Closing. 
 ARTICLE 6 
 AGREEMENTS RELATING TO THE SHARES AND WARRANTS 
 6.1 Furnishing of
Information. Upon consummation of the IPO, and until the earliest of the time that (i) no Purchaser owns Shares, Warrants or Warrant Shares or (ii) the Warrants have expired, the Company covenants to timely file (or obtain
extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), even
if the Company is not then subject to the reporting requirements of the Exchange Act. As long as any Purchaser owns Shares, Warrants or Warrant Shares, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare
and furnish to the Purchasers and make publicly available in accordance with Rule 144(c) such information as is required for the Purchasers to sell the Shares, Warrants or Warrant Shares, including without limitation, under Rule 144. The
Company further covenants that it will take such further action as any holder of Shares, Warrants or Warrant Shares may reasonably request, to the extent required from time to time to enable such holder to sell such Shares, Warrants or Warrant
Shares without registration under the Securities Act, including without limitation, within the requirements of the exemption provided by Rule 144. 
 6.2 Reservation of Common Stock. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a
sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants. 

6.3 Listing of Common Stock. Upon consummation of the IPO, the Company hereby agrees to use best efforts to maintain the
listing or quotation of the Common Stock on the New York Stock Exchange (the “NYSE”), and concurrently with the Closing, the Company shall apply to list all of the Shares and Warrant Shares on the NYSE and promptly secure the
listing of all of the Shares and Warrant Shares on the NYSE. The Company further agrees, if the Company applies to have the Common Stock traded on any other trading market, including the NYSE AMEX, the Nasdaq Capital Market, the Nasdaq Global Market
or the Nasdaq Global Select 

  
 6 








 
Market (or any successors to any of the foregoing) it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of
the Shares and Warrant Shares to be listed on such other trading market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a trading market and will
comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the trading market. 
 ARTICLE 7 
 MISCELLANEOUS 

7.1 Termination. This Agreement shall be terminated prior to the Closing if, prior to the consummation of the IPO Closing, the
Registration Statement is withdrawn or the Underwriting Agreement is terminated pursuant to its terms. In the event of any termination of this Agreement, this Agreement shall become void and have no effect, without any liability to either party
hereto, except for any liability resulting from a breach of this Agreement by either party hereto prior to such termination. 

7.2 Survival. Each of the representations and warranties contained in this Agreement shall survive indefinitely. Each covenant
contained in this Agreement shall survive the Closing until performed in accordance with its terms. 
 7.3 Amendments;
Waivers. The provisions of this Agreement may not be amended or modified except by a writing signed by each party hereto. No waiver of any term or condition hereof or obligation hereunder shall be valid unless made in writing and signed by the
party to which any such performance is due. 
 7.4 Severability of Provisions. If any term, provision, covenant or
restriction of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and
effect and shall in no way be affected, impaired or invalidated so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to either party hereto. Upon such a determination,
the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in an acceptable manner in order that the transactions contemplated hereby be consummated as
originally contemplated to the fullest extent possible. 
 7.5 Equal Treatment of Purchasers. No waiver or
modification of any provision of this Agreement, the Warrants and any other documents or agreements executed in connection with the transactions contemplated hereunder (the “Transaction Documents”), shall be offered or made to any
provision of any of the Transaction Documents unless the same waiver or modification is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each
Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise. 

  
 7 








 7.6 Independent Nature of Purchasers’ Obligations and Rights. The
obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any
other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to
be joined as an additional party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in their review and negotiation of the Transaction Documents. The Company has elected to provide all
Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. 
 7.7 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to any conflict of laws principles thereof that
would cause the application of the laws of another jurisdiction. 
 7.8 Waiver of Trial By Jury. TO THE EXTENT PERMITTED
BY APPLICABLE LAW, EACH PARTY HERETO IRREVOCABLY WAIVES ALL RIGHT OF TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR ANY MATTER ARISING HEREUNDER. 

7.9 Remedies and Waivers. No delay or omission on the part of either party hereto in exercising any right, power or remedy
provided by law or under this Agreement shall (i) impair such right, power or remedy or (ii) operate as a waiver thereof. The single or partial exercise of any right, power or remedy provided by law or under this Agreement shall not
preclude any other or further exercise of any other right, power or remedy. The rights, powers and remedies provided in this Agreement are cumulative and not exclusive of any rights, powers and remedies provided by law. 

7.10 Notices. All notices, requests, demands, waivers and other communications to be given by either party hereto hereunder shall
be in writing and shall be (i) mailed by first-class, registered or certified mail, postage prepaid, (ii) sent by hand delivery or reputable overnight delivery service or (iii) transmitted by fax (provided that a copy is also sent by
reputable overnight delivery service) addressed to the General Counsel of the Issuer or the General Counsel of the Purchasers, as applicable, in each case at c/o Angelo, Gordon & Co., L.P., 245 Park Avenue, 26th Floor, New York, New York
10167, or such other address as may be specified in writing to the other party hereto. All such notices, requests, demands, waivers and other communications shall be deemed to have been given and received (i) if by personal delivery or fax, on
the day of such delivery, (ii) if by first-class, registered or certified mail, on the fifth business day after the mailing thereof or (iii) if by reputable overnight delivery service, on the day delivered. 

  
 8 








 7.11 Execution in Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute but one and the same instrument. 
 7.12 Headings. The Article and Section headings contained herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement. 

7.13 Entire Agreement. This Agreement contains the entire understanding of the parties hereto with respect to the subject matter
hereof, and supersedes all prior agreements and understandings, both written and oral, among the parties hereto with respect to the subject matter hereof. 
 [Signature page follows.] 

  
 9 








 IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the
date first written above. 
  

			
	 ISSUER:
  

AG MORTGAGE INVESTMENT TRUST, INC.
  

	By:	 	  

		 	Name:
		 	Title:


 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK 

SIGNATURE PAGE FOR PURCHASER FOLLOWS] 







 PURCHASER SIGNATURE PAGES TO UNIT PURCHASE AGREEMENT 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
 Name of Purchaser:
                                         
                                         
                                         
                  
 Signature of Authorized Signatory
of Purchaser:
                                         
                                         
               
 Name of Authorized Signatory:
                                         
                                         
                                         
  
 Title of Authorized Signatory:
                                         
                                         
                                         
  
 Email Address of Authorized Signatory:
                                         
                                         
                           
 Facsimile Number of Authorized Signatory:
                                         
                                         
                       

Address for Notice of Purchaser: 

                         
                                         
                       

                         
                                         
                       

                         
                                         
                       
 DWAC
Instructions for Issuance of Shares: 

                         
                                         
                       

Address for Delivery of Securities for Purchaser (if not same as address for notice): 
                                  
                                         
               

                         
                                         
                       

                         
                                         
                       

Subscription Amount: $         
 Number of Units:                          

EIN Number (if applicable):
                         
 [SIGNATURE PAGES CONTINUE] 







 EXHIBIT A 

FORM OF WARRANT AGREEMENT 







 EXHIBIT B 

FORM OF REGISTRATION RIGHTS AGREEMENT 







 EXHIBIT C-1 

FORM OF LOCK-UP AGREEMENT FOR EACH PURCHASER 
 OTHER THAN AG FUNDS, L.P. 







 EXHIBIT C-2 

FORM OF LOCK-UP AGREEMENT FOR AG FUNDS, L.P.